72 Investment Holdings, LLC
Follow13F filer, CIK 1832749, STAMFORD, CT
72 Investment Holdings, LLC reported $49,110,537 across 7 holdings for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000902664-25-001046
- Period
- 2024-12-31
- Reported value
- $49.1M
- Holdings
- 7
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Holdings, Q4 2024
Share positions as resolved from 13F-HR 0000902664-25-001046, largest first. % of portfolio is the value over $49,110,537, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| LENZLENZ THERAPEUTICS INC | 1,017,751 | $29.4M | 59.83% | 0 | Timeline | ||
| KRROKORRO BIO INC | 276,831 | $10.5M | 21.46% | 0 | Timeline | ||
| PRAXPRAXIS PRECISION MEDICINES I | 65,933 | $5.07M | 10.33% | 0 | Timeline | ||
| ANROALTO NEUROSCIENCE INC | 667,778 | $2.82M | 5.75% | 0 | Timeline | ||
| CRBUCARIBOU BIOSCIENCES INC | 474,067 | $754K | 1.53% | 0 | Timeline | ||
| TURNSTONE BIOLOGICS CORPTURNSTONE BIOLOGICS CORP | 549,980 | $273K | 0.56% | 0 | |||
| OMEGA THERAPEUTICS INCOMEGA THERAPEUTICS INC | 352,941 | $263K | 0.54% | 0 |
How Q4 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000902664-25-001046 | base | 2025-02-14 | acceptance time not in the bulk data set |